{
    "root": "8cca69ed-8f6e-4c81-85d2-9861ea182215",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Cephalexin",
    "value": "20240308",
    "ingredients": [
        {
            "name": "CEPHALEXIN",
            "code": "OBN7UDS42Y",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3534"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        }
    ],
    "indications": {
        "text": "cephalexin cephalosporin antibacterial indicated treatment following infections caused susceptible isolates designated bacteria : respiratory tract infection ( 1.1 ) otitis media ( 1.2 ) skin skin structure infections ( 1.3 ) bone infections ( 1.4 ) genitourinary tract infections ( 1.5 ) reduce development drug-resistant bacteria maintain effectiveness cephalexin antibacterial drugs , cephalexin used treat infections proven strongly suspected caused bacteria . ( 1.6 )",
        "doid_entities": [
            {
                "text": "otitis media (DOID:10754)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10754"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "adults patients least 15 years age usual dose 250 mg every 6 hours , dose 500 mg every 12 hours may administered ( 2.1 ) pediatric patients ( 1 year age ) otitis media : 75 100 mg/kg equally divided doses every 6 hours ( 2.2 ) : 25 50 mg/kg given equally divided doses ( 2.2 ) severe infections : 50 100 mg/kg may administered equally divided doses ( 2.2 ) duration therapy ranges 7 to14 days depending infection type severity . ( 2 ) adjustment required patients severe end stage renal disease ( esrd ) defined creatinine clearance 30 ml/min . ( 2.3 )",
        "doid_entities": [
            {
                "text": "otitis media (DOID:10754)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10754"
            },
            {
                "text": "end stage renal disease (DOID:783)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_783"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "cephalexin capsules , usp 500 mg capsules white white powder filled size 0 capsules ( light green cap light green body ) imprinted \u201c 219 \u201d cap body edible black ink . available follows : ndc : 72162-1830-1 : 100 capsules bottle ndc : 72162-1830-5 : 500 capsules bottle ndc : 72162-1830-2 : 500 capsules bottle store 20\u00b0c 25\u00b0c ( 68\u00b0f to77\u00b0f ) ; excursions permitted 15 30\u00b0c ( 59 86\u00b0f ) [ usp controlled room temperature ] . repackaged/relabeled : bryant ranch prepack , inc. burbank , ca 91504",
    "adverseReactions": "cephalexin contraindicated patients known hypersensitivity cephalexin members cephalosporin class antibacterial drugs .",
    "indications_original": "Cephalexin is a cephalosporin antibacterial drug indicated for the treatment of the following infections caused by susceptible isolates of designated bacteria: Respiratory tract infection ( 1.1 ) Otitis media\u00a0\u00a0( 1.2 ) Skin and skin structure infections \u00a0( 1.3 ) Bone infections (1.4) Genitourinary tract infections ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin and other antibacterial drugs, Cephalexin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. (1.6)",
    "contraindications_original": "Adults\u00a0and patients\u00a0at\u00a0least 15\u00a0years\u00a0of\u00a0age The\u00a0usual dose is 250 mg every 6 hours, but a dose of 500 mg every 12 hours may be administered ( 2.1 ) Pediatric patients\u00a0(over\u00a01 year\u00a0of\u00a0age) Otitis media: 75 to 100 mg/kg in equally divided doses every 6 hours\u00a0( 2.2 ) All\u00a0other indications: 25 to 50 mg/kg given in equally divided doses ( 2.2 ) In\u00a0severe infections: 50 to 100 mg/kg may be administered in equally divided doses ( 2.2 ) Duration of therapy ranges from 7 to14 days depending on the infection type and severity.\u00a0( 2 ) Dosage adjustment is required in patients with severe and end stage renal disease (ESRD) defined as creatinine clearance below 30 mL/min. ( 2.3 )",
    "warningsAndPrecautions_original": "Cephalexin capsules, USP\n                  \n                  The 500 mg capsules are a white to off white powder filled into size 0 capsules (light green cap and light green body) that are imprinted with \u201c219\u201d on the both cap and body in edible black ink. They are available as follows:\n                  NDC: 72162-1830-1: 100 Capsules in a BOTTLE\n                  NDC: 72162-1830-5: 500 Capsules in a BOTTLE\n                  NDC: 72162-1830-2: 500 Capsules in a BOTTLE\n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to77\u00b0F); excursions permitted to 15 to 30\u00b0C (59 to 86\u00b0F) [see USP Controlled Room Temperature].\n                  Repackaged/Relabeled by:\n                  Bryant Ranch Prepack, Inc.\n                  Burbank, CA 91504",
    "adverseReactions_original": "Cephalexin is contraindicated in patients with known hypersensitivity to cephalexin or other members of the cephalosporin class of antibacterial drugs.",
    "drug": [
        {
            "name": "Cephalexin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3534"
        }
    ]
}